Vg Life Financials

We advise to exercise Vg Life Sciences fundamental analysis to find out if markets are today mispricing the firm. Strictly speaking this technique allows you to confirm available fundamental indicators of Vg Life Sciences as well as the relationship between them. We were able to break down and interpolate twenty-four available financial indicators for Vg Life, which can be compared to its peers in the sector.
  
Please note, the imprecision that can be found in Vg Life's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Vg Life Sciences. Check Vg Life's Beneish M Score to see the likelihood of Vg Life's management manipulating its earnings.

Vg Life Stock Summary

Vg Life competes with Ayala Pharmaceuticals. VG Life Sciences Inc., a biotechnology company, researches and develops a pipeline of transformative therapies for combat cancer, infectious diseases, and autoimmune diseases caused by chronic inflammation. VG Life Sciences Inc. operates as a subsidiary of Feelux Co., Ltd. VG Life operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 1 people.
InstrumentUSA Pink Sheet View All
ExchangePINK Exchange
ISINUS91822T1016
Business Address121 Gray Avenue,
SectorBiotechnology
IndustryHealth Care
BenchmarkDow Jones Industrial
Websitewww.vglifesciences.com
Phone805 879 9000
CurrencyUSD - US Dollar

Vg Life Key Financial Ratios

There are many critical financial ratios that Vg Life's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Vg Life Sciences reports annually and quarterly.

VGLS Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Vg Life's current stock value. Our valuation model uses many indicators to compare Vg Life value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Vg Life competition to find correlations between indicators driving Vg Life's intrinsic value. More Info.
Vg Life Sciences is rated first in return on asset category among its peers. It is rated first in current valuation category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Vg Life's earnings, one of the primary drivers of an investment's value.

Additional Tools for VGLS Pink Sheet Analysis

When running Vg Life's price analysis, check to measure Vg Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vg Life is operating at the current time. Most of Vg Life's value examination focuses on studying past and present price action to predict the probability of Vg Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vg Life's price. Additionally, you may evaluate how the addition of Vg Life to your portfolios can decrease your overall portfolio volatility.